ESO Lymphoma Course
A

Should We Add Other Agents Like Obinutuzumab, Lenalidomide, Bortezomib or Ibrutinib to R-CHOP? How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis?

By ESO Lymphoma Course FEATURING Andrew Davies
September 3, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Indy Hematology Review

17th Indy Hematology Review

Sat, Aug 15, 2020
The Asian Oncology Society 1st International Conference

The Asian Oncology Society 1st International Conference

Sun, Aug 16, 2020
15:50
Indy Hematology Review

Treatment Algorithm for DLBCL

Feat. J. Leonard
17:49
Jonathan Friedberg

How to Improve on RCHOP for DLBCL: Role of Novel Agents

22:02
2018 Pan Pacific Lymphoma Conference

New Antibody-Drug Conjugates

Feat. B. Kahl
10:46
2018 Pan Pacific Lymphoma Conference

New Approaches to Initial treatment of DLBCL: R-CHOP +

Feat. N. Bartlett
15:30
2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Who is "FIT" f...

Feat. L. Sehn
10:00
2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment Using Immune Checkpoint Inhibitors

Feat. J. Gribben
22:03
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Frontline Strategy for Aggressive Lymphoma - Can we Replace RCHOP?

Feat. J. Westin
09:38
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

R/R DLBCL: Auto-transplant in the Pre-Rituximab Era, Polatuzumab Vedotin...

Feat. C. Flowers
12:47
2019 Scripps MD Anderson's Oncology Update

Lymphoma Practicing Changing ASCO19 Studies: Novel Agents Prior to R-Cho...

Feat. A. Saven
09:28
2018 Pan Pacific Lymphoma Conference

Novel Cell Pathway Targeted Agents for Relapsed DLBCL

Feat. J. Vose
19:22
2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Anthracyclines...

Feat. L. Sehn
06:37
Cleveland Clinic's 20th Annual ASH Review

2019 ASH Review on Limited Stage DLBCL: Can We Use PET Scan to Tailor th...

Feat. B. Hill
16:06
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Rituximab, Lenalidomide, and Ibrutinib Prior to Chemo in Newly Diagnosed...

Feat. C. Flowers
22:17
ESO Lymphoma Course

First Line DLBCL: How Many Cycles of RCHOP? Improving Outcomes of CHOP: ...

Feat. A. Davies
07:21
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Lymphomas: Should You Abandon ASCT in Patients With ...

Feat. N. Mehta-Shah
16:55
Laurie H. Sehn

Polatuzumab Vedotin in the Treatment of DLBCL: OS Significantly Longer w...

10:59
2018 Pan Pacific Lymphoma Conference

A Brief Introduction to the Evolving Role of Genomics in NHL with Case E...

Feat. A. Zelenetz
16:44
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

How I Treat Double Hit Lymphoma

Feat. K. Dunleavy
28:25
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Does RCHOP Stay the Standard of Care After 6 Cycles in Advanced/R DLBCL?...

Feat. A. Younes
17:51
2018 Pan Pacific Lymphoma Conference

Optimum Therapy for Standard Risk High Grade - DLBCL

Feat. N. Bartlett